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Abstract 
The importance of the working document is that it allows analyzing the information and the status of the 
cases associated with (SARS-CoV-2) COVID-19 as data open to the municipal government and especially in 
the Totonacapan Zone in Mexico, from the registry patient diary, according to age, sex, comorbidities and 
condition of (SARS-CoV-2) COVID-19, according to the following characteristics: a) Positive, b) Negative, c) 
Suspect. Likewise, it presents information on the identification of an outpatient and / or hospitalized 
patient, attending to their medical development, identifying: a) Recovered, b) Deaths and c) Assets. Data 
analysis is carried out by applying a data mining algorithm, which provides the information, fast and timely, 
necessary for the estimation of the healthcare scenarios of (SARS-CoV-2) COVID-19. 
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Specifications Table 
Subject Infectious Diseases 
Specific subject area Information from the Viral Respiratory Diseases Epidemiological 
Surveillance System for (SARS-CoV-2) COVID-19 in the Totonacapan Zone 
- Mexico 
Type of data Table 
Figure 
How data were acquired Government of Mexico. Health Secretary. Databases Covid-19 México 
https://datos.gob.mx/busca/dataset/informacion-referente-a-casos- 
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 
Instruments: 
Software Orange Data Mining version 3.26.0 https://orange.biolab.si 
Make and model and of the instruments used: 
Algorithm for the identification of patients according to following 
characteristics: a) Positive, b) Negatives, c) Suspects. Likewise, it presents 
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 information regarding the identification of an outpatient and / or 
hospitalized patient, attending to their medical development, identifying: 
a) Recovered, b) Deaths and c) Assets 
Data format The information is presented in raw in CVS format, the Ministry of Health 
of Mexico since April 14, 2020 published the cases associated with (SARS- 
CoV-2) COVID-19 as open data. The data processing corresponds to the 
records on the epidemic (SARS-CoV-2) COVID-19 at 15 July 2020. The 
treatment of the information is carried out through the application 
software for data mining Orange version 3.26.0, in which the algorithm for 
the analysis of information is filtered to present the current scenario in 
Mexico of the SARS-CoV-2 (COVID 19). 
Parameters for data 
collection 
The study area corresponds to the variant identified as Totonaco de la 
Costa and that identifies the Totonacapan Zone from the political and 
administrative integration of the municipalities of Cazones de Herrera, 
Coahuitlán, Coatzintla, Coxquihui, Coyutla, Chumatlán, Espinal, Filomeno 
Mata, Gutiérrez Zamora, Mecatlán, Papantla, Poza Rica, Tecolutla, 
Tihuatlán and Zozocolco de Hidalgo. The information is presented at the 
municipal level, and particularly in the municipalities that make up the 
Totonacapan Zone from a daily registry of patients, according to age, sex, 
comorbidities, for the condition for positive results of (SARS-CoV-2) COVID 
-19, presenting the following characteristics: a) Positive, b) Negatives, c) 
Suspects. It also presents information on the identification of an outpatient 
and / or hospitalized patient, attending to their medical development, 
identifying: a) Recovered, b) Deaths and c) Assets. 
Description of data 
collection 
This information is filtered to present the current scenario in the 
Totonacapan Zone in Mexico of the SARS-CoV-2 (COVID 19) in a fast and 
timely manner, to support public decision-making in health matters. 
Data source location Institution: Universidad Veracruzana / Instituto de Investigaciones y 
Estudios Superiores Económicos y Sociales.  Country: México 
Data accessibility Raw data can be retrieved from the Github repository 
https://github.com/CMedelR 
 
Value of the Data 
• The Algorithm for the identification of patients (SARS-CoV-2) COVID 19 in the Totonacapan Zone in 
Mexico allows to analyze at the municipal level the registry of patients, according to age, sex, 
comorbidities, indigenous speech condition and  condition of (SARS-CoV-2) COVID-19 according to 
the following characteristics: a) Positive, b) Negative, c) Suspicious, as well as presenting 
information on the identification of an outpatient and / or hospitalized patient, attending to their 
medical development in Phase 3 and Phase 4, in a fast and timely manner, to support public 
decision-making in health matters. 
• Taking into account their strategic roles in public health and researchers can use the data from 
this study to identify the action scenario for decision-making in the combat of (SARS-CoV-2) COVID 
19 in Phase 3 and Phase 4. 
• The importance of data analysis is that it allows identifying the cases (SARS-CoV-2) COVID-19 in 
Mexico is concentrated on a daily for patients of (SARS-CoV-2) COVID-19 and and allows preparing 
action scenarios for making public health policy decisions to combat SARS-CoV-2) COVID-19 in in 
the Totonacapan Zone in Mexico. 
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Data Description 
 
The source of information on the number of registered cases of (SARS-CoV-2) COVID-19 at 15 July 2020 
for Mexico comes from the website https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-
covid-19-en-mexico/resource/e8c7079c-dc2a-4b6e-8035-08042ed37165 by the Ministry of Health, with 
the participation of the National Council for Science and Technology (CONACYT), the Center for Research 
in Geospatial Information Sciences (CENTROGEO), the National Laboratory for Geo-Intelligence (GEOINT), 
the Data Laboratory of the National Laboratory for Geointelligence (DataLab), where the registry of 
COVID-19 cases (SARS-CoV-2) COVID-19 is concentrated, and is the official means of communication and 
information on the epidemic in Mexico. 
 
The information of the cases (SARS-CoV-2) COVID-19 in Mexico is concentrated on a daily basis since April 
19, 2020, communication and official information on the epidemic in Mexico, the data are presented at 
the municipal, state and national levels, with a daily registry of patients, according to age, sex, 
comorbidities, for the condition of (SARS-CoV-2) COVID-19 according to the following characteristics: a) 
Positive, b) Negatives, c) Suspects. Likewise, it presents information regarding the identification of an 
outpatient and / or hospitalized patient, attending to their medical development. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at July 15, 2020. The treatment of 
the information is carried out through the application software for data mining and visual programming 
Orange Data Mining version 3.26.0. Orange Data Mining is a machine learning and data mining suite for 
data analysis through Python scripting and visual programming. [1] 
 
According to (WHO, 2020) the (SARS-CoV-2) COVID-19 disease pattern presents 4 scenarios identified 
from the confirmation of Laboratory Diagnosis: a) Not Infected or b) Infected, in this finally, the following 
categories are observed, taking into account age and specific comorbidities in each case: a) Mild Infection, 
a) Moderate Infection, c) Severe Infection and d) Critical Infection. 
 
Depending on the category observed in Patients who have a Confirmation of Infected, as in the case of a) 
or b) it can assume the character of Outpatient, so the strategy is isolation or "quarantine" at home, where 
the result It is hoped that he will recover. Regarding the Patients who have a Confirmation of Infected, in 
categories c) and d) they assume the character of Hospitalized Patient, with a probability of requiring care 
in Intensive Care Units and requiring Intubation, and where it is hoped to save as many patients as 
possible. 
 
The importance of the research is that it allows identifying the action scenario for making public health 
policy decisions to combat CO(SARS-CoV-2) COVID-19, since they consider the following states of process 
in medical treatment, in order to carry out the Estimate of Scenarios for Medical Care of the (SARS-CoV- 
2) COVID-19 in the Totonacapan Zone in Mexico under the following premises of hospital care: 
1. A patient with a positive (SARS-CoV-2) COVID-19 laboratory diagnosis can be considered: a) 
Outpatient, or b) Hospitalized. 
2. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized, the following should be considered: a) 
Enter the Intensive Care Unit or b) Do not enter the Intensive Care Unit. 
3. If the (SARS-CoV-2) COVID-19 Positive patient is Hospitalized and Entered into the Intensive Care 
Unit, the following should be considered: a) The patient requires intubation or b) The patient does 
NOT require intubation. 
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Methods 
The information is presented in raw in CVS format, the Ministry of Health of Mexico. The data processing 
corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 15 July 2020. The treatment of the 
information is carried out through the application software for data mining Orange version 3.26.0, in 
which the algorithm for the analysis of information are developed and it is filtered to present the current 
scenario in the Totonacapan Zone in  Mexico of the SARS-CoV-2 (COVID 19). In this way, the algorithm 
that is presented allows us to project the requirements for the use of installed infrastructure in the face 
of the growing requirement for patient care Positive (SARS-CoV-2) COVID-19, allowing the identification 
of scenarios at the national, state and municipal levels. The construction of the algorithm is based on the 
following definitions. (See Figure 1 at the end of the section). 
 
Definition 1: Total Patients to consider in Model (SARS-CoV-2) COVID-19.- It is the number of total patients 
according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
 
Be: 
TP SARS-CoV-2 i j = Total patients according to (SARS-CoV-2) COVID-19 confirmatory laboratory result 
 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- SARS-CoV-2 i j) + (Px SARS-CoV-2 i j), where: i = State, j = 
Totonacapan Zone 
 
Of which: 
P+ SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Totonacapan Zone 
P- SARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Totonacapan Zone 
Px SARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State, Totonacapan 
Zone 
 
Definition 2: Identification of a suspected (SARS-CoV-2) COVID-19 case.- This is the patient who undergoes 
an initial qualification according to the initial diagnostic characteristics indicated in the case definitions 
for surveillance by the World Health Organization for primary care of (SARS-CoV-2) COVID-19 cases. 
 
Be: 
CsCOVID 19 (SARS-CoV-2) = Patient with initial classification as a suspected case of (SARS-CoV-2) COVID 19 
 
Where: 
Cs (SARS-CoV-2) COVID-19 = Cs (SARS-CoV-2) COVID-19 Type 1 + Cs (SARS-CoV-2) COVID-19 Type 2 + Cs 
(SARS-CoV-2) COVID-19 Type 3 
 
Of which: 
According to the World Health Organization, there are 3 categories (identified as Type 1, Type 2 and Type 3) 
to identify suspected cases of (SARS-CoV-2) COVID-19, defined below: 
 
1. Cs (SARS-CoV-2) COVID-19 Type 1.- Is a patient with acute respiratory disease (fever and at least 
one sign / symptom of respiratory disease, with no other aetiology that fully explains the clinical 
presentation and a history of travel or residence in a country / area or territory that reports local 
transmission of COVID-19 disease during the 14 days prior to the on set of symptoms. 
2. Cs (SARS-CoV-2) COVID-19 Type 2.- He is a patient with an acute respiratory disease, who has 
been in contact with a confirmed or probable COVID-19 case in the last 14 days before the onset 
of symptoms. 
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3. Cs (SARS-CoV-2) COVID-19 Type 3.- Is a patient with severe acute respiratory infection (fever and 
at least one sign / symptom of respiratory illness (e.g. cough, shortness of breath) and requiring 
hospitalization and without another etiology that fully explains the clinical presentation. 
 
Definition 3: Total Patients to consider in the (SARS-CoV-2) COVID-19 Model .- It is the number of total 
patients according to the confirmatory laboratory result or not of (SARS-CoV-2) COVID-19). 
 
Be: 
TP SARS-CoV-2 i j = Total patients according to confirmatory laboratory result or not of (SARS-CoV-2) 
COVID-19 
 
Which consists of: 
TP SARS-CoV-2 i j = (P + SARS-CoV-2 i j) + (P- ARS-CoV-2 i j) + (Px ARS-CoV-2 i j) , where: i = State, j =  
Totonacapan Zone 
Of which: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Totonacapan Zone 
P- ARS-CoV-2 i j = Patient with negative (SARS-CoV-2) COVID-19 result in the State, Totonacapan Zone 
Px ARS-CoV-2 i j = Patient with pending confirmation (SARS-CoV-2) COVID-19 in the State,  Totonacapan Zone 
 
Definition 4: Positive Patients for (SARS-CoV-2) COVID-19 i j.- It is the number of patients with laboratory 
results with positive confirmation for (SARS-CoV-2) COVID-19 i j . 
 
It has: 
P + SARS-CoV-2 i j = Patient with a positive (SARS-CoV-2) COVID-19 result in the State, Totonacapan Zone 
 
Definition 5.- Medical Treatment Strategy for a patient with positive laboratory confirmation for (SARS- 
CoV-2) COVID-19 i j .- It is the Action Plan in Medical Treatment for a patient with positive laboratory 
confirmation for SARS-CoV-2 in attention to your degree of infection and comorbidities present that is 
channeled to determine the Physician. 
 
According to the Strategy of Medical Care required for Patients with a Positive SARS-CoV-2 Result, 
according to their degree of identified infection, they have the following. 
 
Be:          ET P + SARS-CoV-2 i j = Medical Treatment Strategy P + SARS-CoV-2 i j 
 
The medical treatment for a patient with a positive laboratory result for (SARS-CoV-2) COVID-19, based 
on the Medical Treatment Strategy (ETM P + SARS-CoV-2 ij), based on his degree of infection and present 
comorbidities, poses two action scenarios : i) Outpatient (SARS-CoV-2) COVID-19 patient or ii) Hospitalized 
(SARS-CoV-2) COVID-19 patient. 
Be: 
i) Outpatient COVID19 patient. 
P + SARS-CoV-2 i j Outpatient = Positive (SARS-CoV-2) COVID-19 with Outpatient mode in the State, 
Totonacapan Zone 
ii) COVID19 Patient Hospitalized. 
P + SARS-CoV-2 i j Hospitalized = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the 
State, Municipality 
where: 
Depending on the degree of infection (I1, I2 or I3), the Hospitalized (SARS-CoV-2) COVID-19 Patient may 
require: i) Access to the Intensive Care Area without Intubation or ii) Access to the Intensive Care Area 
with Intubation.
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Definition 6.- Patients with a Positive (SARS-CoV-2) COVID-19 Result Hospitalized with Access to the 
Intensive Care area.- It is the number of Patients with a Positive SARS-CoV-2 Result Hospitalized with 
Access to the Intensive Care area, according to its degree of infection. 
 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care = Positive (SARS-CoV-2) COVID-19 with modality Hospitalized in the 
State, Totonacapan Zone. 
 
Definition 7.- Patients with a positive (SARS-CoV-2) COVID-19 result Hospitalized with access to the 
Intensive Care Area with Intubation.- It is the number of Patients with a Positive (SARS-CoV-2) COVID-19 
Result Hospitalized with Access to the Intensive Care area with Intubation. 
Be: 
P + SARS-CoV-2 i j Hospital Intensive Care with Intubation = Positive (SARS-CoV-2) COVID-19 with Hospitalized 
modality and intubation in the State, Totonacapan Zone. 
 
Definition 8.- P + SARS-CoV-2 i j Deaths.- Deaths of Patients with a positive result for SARS-CoV-2. Deaths 
are all those positive to (SARS-CoV-2) COVID-19 where one is indicated in the data record (DATE_DEF 
other than the value "99-99-9999"). 
 
Definition 9.- (SARS-CoV-2) COVID-19 case fatality rate.- It is the proportion of people who die from (SARS- 
CoV-2) COVID-19 among the Patients with a positive (SARS-CoV-2) COVID-19 result in a given period and 
area. 
Be: 
TL SARS-CoV-2 i j = (SARS-CoV-2) COVID-19 case fatality rate 
 
Where: 
(SARS-CoV-2) COVID-19 case fatality rate = [(Deaths of Patients with a Positive (SARS-CoV-2) COVID-19 Result in 
the State or Municipality) / (Total of Patients with a Positive (SARS-
CoV-2) COVID-19 result in the State or Totonacapan Zone)] x 100 
 
Of which: 
DP+ SARS-CoV-2 i j = Deaths of Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality 
And: 
P+ SARS-CoV-2 i j = Total Patients with a positive (SARS-CoV-2) COVID-19 result in the State / Municipality  
So: 
TL SARS-CoV-2 i j = [D P + SARS-CoV-2 i j / P + SARS-CoV-2 i j] x 100 
 
The data processing corresponds to the records on the epidemic (SARS-CoV-2) COVID-19 at 16 July 2020. 
The treatment of the information is carried out through the application software for data mining Orange 
version 3.26.0, in which the algorithm for the information analysis are developed. (See Table 1 and Figure 
1, below). According to information from the Ministry of Health, the following records are available at the 
national level: 
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1. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 324,041 of which: a) 
230,219 are Care Outpatients and b) 93,822 are Hospitalized patients. 
2. Of the 93,822 Hospitalized (SARS-CoV-2) COVID-19 Positive patients:  a) 7,801 patients enter the 
Intensive Care Unit; while b) 86,021 patients do not enter the Intensive Care Unit. 
3. Only 70 Hospitalized (SARS-CoV-2) COVID-19 Positive patients admitted to the Intensive Care Unit 
required intubation are speakers of indigenous language, at the national level, of which: a) 26 are 
women and) 44 are men. 
4. Likewise, to date 56 deaths from positive (SARS-CoV-2) COVID-19 patients speakers of indigenous 
language, at the national level have been registered nationwide. 
 
 
According to information from the Ministry of Health, in the Totonacapan Zone the following records are 
available at the national level: 
 
1. The number of patients with a positive (SARS-CoV-2) COVID-19 result is 1,225 of which: a) 518 are 
women and b) 707 are men. (See Table 2). 
2. The total number of women with a positive (SARS-CoV-2) COVID-19, only 6 are women who speak 
the indigenous language and 512 are women who do not speak the indigenous language. On the 
other hand, the total number of men with a positive (SARS-CoV-2) COVID-19, 17 are men who 
speak the indigenous language and 690 are men who do not speak the indigenous language. (See 
Table 3). 
3.  1,225 patients with (SARS-CoV-2) positive COVID-19, according to their primary hospital care, 
there are: a) 732 are patients who did not require hospitalization and b) 493 are patients who 
required hospitalization. (See Table 4). 
4. 493 patients with (SARS-CoV-2) COVID-19 positive who were hospitalized: a) 15 correspond to 
speakers of the indigenous language and b) 478 are patients who do not speak the indigenous 
language. (See Table 4). 
5. From the 732 patients with (SARS-CoV-2) COVID-19 positive who were not hospitalized, only 8 
were patients speaking the indigenous language and 724 were patients who did not speak the 
indigenous language. (See Table 4). 
6. From the 1,225 patients with positive (SARS-CoV-2) COVID-19, 23 are patients who speak the 
indigenous language and 1,202 correspond to patients who do not speak the indigenous language. 
(See Table 3). 
7. From the 23 patient patients who speak the indigenous language, these come from: Coatzintla 1 
patient, Coxquihui 1, Coyutla 2, Chumatlán 1 and Papantla 12. (See Table 5) 
8. From the 493 Hospitalized (SARS-CoV-2) COVID-19 Positive patients: a) 4 patients enter the 
Intensive Care Unit; while b) 157 patients do not enter the Intensive Care Unit. (See Table 6). 
9. Only  4 Hospitalized (SARS-CoV-2) COVID-19 Positive patients admitted to the Intensive Care Unit 
required intubation. 
10. As of July 16, 2020, there have been 3 deaths of hospitalized patients (SARS-CoV-2) COVID-19 
whose results were positive and were indigenous language speakers in the Totonacapan zone. 
(See Figure 3, at the end of the section, where the associated comorbidities of the indigenous 
language-speaking patients who died in the Totonacapan).
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Table 1. Total number of cases in Mexico as of July 16, 2020, According to 
Sex and Result at (SARS-CoV-2) COVID-1 
 
Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-1 149,637 174,404 324,041 
No positive (SARS-CoV-2) COVID-1 198,824 176,631 375,455 
Pending result   40,948   41,619 82,567 
Total   389,409   392,654 782,063 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of July 16, 2020 
 
Table 2. Total number of cases in Totonacapan Zone in Mexico as of July 16, 
2020, According to Sex and Result at (SARS-CoV-2) COVID-1 
 
Sex  
Result Women Men Total 
Positive (SARS-CoV-2) COVID-1      518      707 1,225 
No positive (SARS-CoV-2) COVID-1      251      247 498 
Pending result         70        75 145 
Total         839     1,029 1,868 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of July 16, 2020 
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Table 3. Total number of cases in Totonacapan Zone in Mexico as of July 16, 
2020, According to sex, indigenous language speaker status 
 and result positive at (SARS-CoV-2) COVID-19 
 
  
Result Women Men Total 
Indigenous language speaker           6         17 23 
Non-indigenous language speaker       507      683 1,190 
Not specified           5          7 12 
Total         518         707 1,225 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of July 16, 2020 
 
 
 
Table 4. Total number of cases in Totonacapan Zone in Mexico as of July 16, 2020, 
According to primary hospital care condition, indigenous language speaker status 
 and result positive at (SARS-CoV-2) COVID-19 
 
  
Result Non Hospitalized Hospitalized Total 
Indigenous language speaker           8         15 23 
Non-indigenous language speaker       720       470 1,190 
Not specified           4          8 12 
Total         732         493 1,225 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of July 
16, 2020 
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Table 5. Total number of cases in Totonacapan Zone in Mexico as of July 16, 
2020, According to primary indigenous language speaker status 
 and result positive at (SARS-CoV-2) COVID-19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. 
Health Secretary. Epidemiological Surveillance System for Viral Respiratory 
Diseases as of July 16, 2020 
 
Table 6. Total number of cases in Totonacapan Zone in Mexico as of July 16, 2020, 
According to primary indigenous language speaker status, result positive  at 
(SARS-CoV-2) COVID-19 and status according to primary hospital care condition in 
Intensive care unit 
 
Source: Own elaboration with Government of Information from the Mexico. Health 
Secretary. Epidemiological Surveillance System for Viral Respiratory Diseases as of 
July 16, 2020 
Municipality Speak 
indigenous 
language 
Non 
Speak 
indigenous 
language  
Not specified Total 
Cazones de 
Herrera 
0 14 0 14 
Coatzintla 1 102 1 104 
Coxquihui 1 2 0 3 
Coyutla 2 4 0 6 
Chumatlán 1 0 0 1 
Espinal 0 8 0 8 
Filomeno Mata 0 1 0 1 
Gutierrez Zamora 0 20 0 20 
Mecatlan 0 1 0 1 
Papantla 12 168 2 182 
Poza Rica 6 775 9 790 
Tecolutla 0 8 0 8 
Tihuatlán 0 87 0 87 
Total 23 1,190 12 1,225 
Municipality Intensive 
care unit 
Non  Intensive 
care unit 
Not  
specified 
Total 
Cazones de Herrera 0 4 0 4 
Coatzintla 1 8 1 10 
Coxquihui 0 1 0 1 
Coyutla 0 2 0 2 
Espinal 0 1 0 1 
Gutierrez Zamora 0 4 0 4 
Papantla 3 13 0 16 
Poza Rica 0 100 2 102 
Tihuatlán 0 21 0 21 
Total 4 154 3 161 
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Figure 1. Algorithm for the identification of patients 
(SARS-CoV-2) COVID 19 in the Totonacapan Zone in Mexico  
Orange Data Mining version 3.26.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Own elaboration with Government of Information from the Mexico. Health Secretary. Epidemiological Surveillance System for 
Viral Respiratory Diseases as of July 16, 2020 and Software Orange Data Mining version 3.26.0. 
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Figure 2. Comorbidities in patients with a positive result in (SARS-CoV-2) COVID-19, speakers of the 
indigenous language in the Totonapacapan area, according to sex and age groups
 
Technical note: 1 = Woman (o), 2 = Man (x) 
Source: Own elaboration with Government of Information from the Mexico. Health Secretary. 
Epidemiological Surveillance System for Viral Respiratory Diseases as of July 16, 2020 
 
 
 
 
 
 
 
 
 
 
 
 
 
13  
 
Figure 3. Comorbidities in deceased patients who presented with a positive result for COVID-19 (SARS-CoV-
2), speakers of the indigenous language in the Totonapacapan area, according to sex and age groups 
 
Technical note: 1 = Woman (o), 2 = Man (x) 
Source: Own elaboration with Government of Information from the Mexico. Health Secretary. 
Epidemiological Surveillance System for Viral Respiratory Diseases as of July 16, 2020 
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